The latest in RA therapies, and what you can expect from the pipeline.
Here’s five things to take away from Anthem’s launch of PBM IngenioRx.
HCCI Releases 2017 Health Care Cost and Utilization Report. Here are the revealing findings.
A new study suggests that the FDA and manufacturers did not act when evidence emerged that potentially lethal fentanyl products were being inappropriately prescribed to patients.
A group of community providers around Charlotte, North Carolina, joined to create a special workgroup to ensure that veterans have the best possible support to lead healthy lives.
Aetna and Apple partner on a new wellness app that combines activity-driven incentives and rewards with personalized health recommendations. Experts share their reactions.
Louisiana’s subscription model aims to rein in the hepatitis C epidemic in the state.
Behavioral health services company Beacon Health Options brings outpatient mental health therapy to a Texas Walmart store. Here’s how experts say it will affect managed care.
The partial government shutdown is affecting the country in many ways—but how is it interfering with biosimilar development?
While the government shutdown doesn’t directly affect HHS, the shutdown is having profound and long-lasting effects on the U.S. healthcare system.